At a glance
ClinicalIndex Comparison RecordN/ACompleted· 268 enrolled
Drug / intervention
etafilcon A with novel molding process +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
In Brief
A clinical study evaluating etafilcon A with novel molding process and etafilcon A with current molding process for Myopia. Completed, enrolled 268 participants across 12 sites.
Detailed Summary
This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedOct 2018
Primary CompletionApr 2019
TodayJul 2026
First PostedOct 10, 2018
Enrollment StartSep 24, 2018
Primary CompletionApr 1, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.7 years ago
Interventions
etafilcon A with novel molding processdevice
TEST Lens
etafilcon A with current molding processdevice
CONTROL Lens